6 Athira Pharma LIFT-AD topline results (press release)September 3, 2024 announcement that fosgonimeton (a distinct HGF/c-Met modulator) did not meet the primary or key secondary endpoints in the Phase 2/3 LIFT-AD Alzheimers trial
The complexity of NO signaling is shaped by its concentration, intracellular localization, and interactions with other molecular pathways, such as H 2 S, underscoring the importance of these contextual factors
Bio-physical and computational studies on serum albumin/target protein binding of a potential anti-cancer agent
Oxidative Medicine and Cellular Longevity, 2017 , 8416763
When you start using a powerful peptide like GHK-Cu, its natural to wonder, How long until I see a difference? While its exciting to anticipate smoother, firmer skin, its helpful to have a realistic timeline in mind
The New Hazlett Center for the Performing Arts and its affiliated companies take no responsibility for the privacy policy or practices of third-party Websites linked to The New Hazlett Center for the Performing Arts